FI955604L - 3-(indol-3-yyli)propenoiinihappojohdannaiset NMDA-antagonisteina - Google Patents

3-(indol-3-yyli)propenoiinihappojohdannaiset NMDA-antagonisteina Download PDF

Info

Publication number
FI955604L
FI955604L FI955604A FI955604A FI955604L FI 955604 L FI955604 L FI 955604L FI 955604 A FI955604 A FI 955604A FI 955604 A FI955604 A FI 955604A FI 955604 L FI955604 L FI 955604L
Authority
FI
Finland
Prior art keywords
indol
acid derivatives
propenoic acid
nmda antagonists
nmda
Prior art date
Application number
FI955604A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955604A7 (fi
FI955604A0 (fi
Inventor
Francesco Gerald Salituro
Bruce Michael Baron
Boyd Lynn Harrison
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI955604A7 publication Critical patent/FI955604A7/fi
Publication of FI955604A0 publication Critical patent/FI955604A0/fi
Publication of FI955604L publication Critical patent/FI955604L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI955604A 1993-05-27 1994-05-02 3-(indol-3-yyli)propenoiinihappojohdannaiset NMDA-antagonisteina FI955604L (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6836793A 1993-05-27 1993-05-27
US13932393A 1993-10-19 1993-10-19
US19081494A 1994-02-02 1994-02-02
PCT/US1994/005023 WO1994027964A1 (en) 1993-05-27 1994-05-02 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists

Publications (3)

Publication Number Publication Date
FI955604A7 FI955604A7 (fi) 1995-11-21
FI955604A0 FI955604A0 (fi) 1995-11-21
FI955604L true FI955604L (fi) 1995-11-21

Family

ID=27371322

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955604A FI955604L (fi) 1993-05-27 1994-05-02 3-(indol-3-yyli)propenoiinihappojohdannaiset NMDA-antagonisteina

Country Status (17)

Country Link
EP (1) EP0701551B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3334805B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100314482B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1051302C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE151750T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU681402B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2161768C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69402703T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0701551T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2103590T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI955604L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3023973T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU216633B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL109744A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO306021B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW262467B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1994027964A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
US5563157B1 (en) 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
KR20000048715A (ko) * 1996-09-30 2000-07-25 게리 디. 스트리트, 스티븐 엘. 네스비트 Nmda (n-메틸-d-아스파르테이트) 길항제
CN101770315B (zh) 2009-01-05 2012-05-23 鸿富锦精密工业(深圳)有限公司 具有滑动控制的触摸电子装置及其滑动控制方法
CN113419009B (zh) * 2021-06-29 2023-02-07 国家烟草质量监督检验中心 一种氟噻虫砜代谢物的液相色谱串联质谱测定方法
CN113419008B (zh) * 2021-06-29 2023-02-07 国家烟草质量监督检验中心 一种氟噻虫砜代谢物的合相色谱串联质谱测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
WO2019021625A1 (ja) * 2017-07-25 2019-01-31 株式会社日立ハイテクノロジーズ 自動分析装置

Also Published As

Publication number Publication date
EP0701551B1 (en) 1997-04-16
GR3023973T3 (en) 1997-10-31
HU216633B (hu) 1999-07-28
JPH09508615A (ja) 1997-09-02
CN1124484A (zh) 1996-06-12
JP3334805B2 (ja) 2002-10-15
CN1051302C (zh) 2000-04-12
WO1994027964A1 (en) 1994-12-08
KR960702438A (ko) 1996-04-27
IL109744A (en) 1999-06-20
FI955604A7 (fi) 1995-11-21
NO306021B1 (no) 1999-09-06
CA2161768C (en) 1998-08-18
HUT74620A (en) 1997-01-28
HU9503367D0 (en) 1996-01-29
ATE151750T1 (de) 1997-05-15
KR100314482B1 (ko) 2002-02-28
CA2161768A1 (en) 1994-12-08
DE69402703T2 (de) 1997-11-27
EP0701551A1 (en) 1996-03-20
NO954769L (no) 1996-01-25
NO954769D0 (no) 1995-11-24
TW262467B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-11-11
FI955604A0 (fi) 1995-11-21
AU6784394A (en) 1994-12-20
IL109744A0 (en) 1994-08-26
ES2103590T3 (es) 1997-09-16
DK0701551T3 (da) 1997-10-20
AU681402B2 (en) 1997-08-28
DE69402703D1 (de) 1997-05-22

Similar Documents

Publication Publication Date Title
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
DK0393936T3 (da) 3-substituerede 2-oxindolderivater som antiinflammatoriske midler
FI905983L (fi) Aminosyraderivat.
FI944800L (fi) Indoli-2-karboksyylihappojohdannaisia
FI960840A7 (fi) Indolijohdannaisia tromboksaani-A2-antagonisteina
KR950700304A (ko) 5ht4-수용체 길항질로서 축합 인돌 유도체(condensed indole derivatives as 5ht4-receptor antagonists)
FI922953A7 (fi) 7-azaisoindolinylkinolon- och naftyridonkarboxylsyraderivat
FI944805A7 (fi) Indolijohdannaisia 5-HT1-kaltaisina agonisteina
FI942923A7 (fi) Propeenihappojohdannaiset
FI940659A7 (fi) Heterosyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia
DK0411150T3 (da) Indolderivater
DE68913137D1 (de) Carbonsäure-Derivate.
FI972684A7 (fi) Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeni antagonisteina
FI962639A0 (fi) Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina
FI921718A7 (fi) Aminohappojohdannaiset
DE68923913D1 (de) Neplanocinderivate.
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
FI953104L (fi) Diaryyli-5,6-kondensoidut heterosykliset hapot leukotrieeniantagonisteina
FI922094A7 (fi) Aminosyraderivat
FI955604L (fi) 3-(indol-3-yyli)propenoiinihappojohdannaiset NMDA-antagonisteina
FI913179A7 (fi) Aminosyraderivat.
FI962768A7 (fi) N-(2-ftaali-imidoetyyli)substituoituja transpiperidiini-2,5-dikarboksy laatteja
FI900641A7 (fi) Indolijohdokset
FI941149L (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
DE69122555D1 (de) 2,4-Dihydroxyadipinsäurederivate